Inovio Pharmaceuticals Inc vs Skyworks Solutions Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Skyworks Solutions Inc trades at $62.99 (market cap $8.99B). The key difference: Skyworks Solutions Inc is far larger — about 100.7× Inovio Pharmaceuticals Inc's market cap, and Skyworks Solutions Inc pays a 4.75% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | SWKS | |
|---|---|---|
Market Cap | $89.27M | $8.99B |
Sector | Health | Technology |
52-Week High | $2.87 | $83.40 |
52-Week Low | $1.05 | $52.50 |
Enterprise Value | $60.28M | $8.76B |
Dividend Yield | — | 4.75% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →